DG DISPATCH - ECFC: CF Patients Have Higher Immune Responses To C. Albicans
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - ECFC: CF Patients Have Higher Immune Responses To C. Albicans

By Martin Goldman
Special to DG News

THE HAGUE, THE NETHERLANDS -- June 14, 1999 -- Patients with cystic fibrosis (CF) have significantly higher immune responses to Candida albicans compared to individuals without the condition as a response to colonisation of the respiratory tract by this yeast.

Dr. L Maiz, of the pneumonology department, Ramon Y. Cajal Hospital, Madrid, Spain, and her colleagues carried out a prospective six-year evaluation, to find the importance of C. albicans and the immune response this produced in patients with cystic fibrosis.

The results were presented at the European Cystic Fibrosis Congress.

A total of 76 cystic fibrosis patients were evaluated over the six-year period and 1,239 samples of respiratory secretions were cultivated for the presence of bacteria. In 66 of these patients, 400 serum samples obtained every three to four months were analysed during the last three years of the study. The researchers evaluated the samples for total IgE, IgG, IgA and IgM against C. albicans using the ELISA assay.

Of the patients studied, 588 respiratory secretion samples were positive for C. albicans (87.9 percent); 90.8 percent presented some kind of immune response against C. albicans. There was a significant correlation between the degree of colonisation and the IgG and IgA against C. albicans and this had an R value of not less than 0.6.

The researchers concluded that patients with cystic fibrosis present significantly higher immune responses to C. albicans compared to normal subjects as a response to colonisation of the respiratory tract. Pulmonary deterioration of the patients facilitates C. albicans colonisation and the degree of colonisation is paralleled by the immune response.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities